GHK-Cu 50 mg ELIXIR product image ELIXIR product image

Research-use-only

GHK-Cu

Mass / variant

Batch-specific documentation COA availability Secure checkout

Lab results

Lot documentation

ELIXIR provides applicable lot-specific laboratory documentation, including COAs, for products offered for sale.

No public COA record is currently displayed for this product selection. Use COA Lookup to search by lot number or product name.

Open COA lookup

All products listed on this site are for research purposes only. Not for human or animal use, diagnostic or therapeutic use, human dosing, injection, ingestion, consumption, administration, or application guidance.

Product Overview

GHK-Cu is a copper-binding tripeptide complex composed of glycyl-L-histidyl-L-lysine coordinated with copper and supplied for research-use-only laboratory applications.

GHK-Cu is studied in metal-peptide coordination chemistry, copper-associated peptide signaling, extracellular-matrix research, and gene-expression models involving peptide-metal complexes.

Its research relevance centers on peptide-metal complex characterization, pathway assays, and controlled laboratory models involving copper-associated peptide chemistry.

Mass Options

  • 50 mgAvailable mass option

Scientific Specifications

Amino Acid Sequence
Gly-His-Lys-Cu(II)
Molecular Formula
C14H21CuN6O4-
Molecular Weight
400.90
PubChem CID
139035031
Synonyms
Copper tripeptide, GHK-Cu, Gly-His-Lys-Cu(II)

Product FAQ

Where are COA and testing documents shown for this product?

Available COAs appear on the relevant product page and in COA Lookup. Search by lot number or product name to find records for a specific batch.

What does Research Use Only mean for this product?

All products listed on this site are for research purposes only. This product and related site information are not for human or animal use, diagnostic use, therapeutic use, human dosing, injection, ingestion, consumption, or administration.

Can ELIXIR provide use, dosing, or reconstitution instructions?

No. ELIXIR does not provide dosing, administration, reconstitution, human-use, animal-use, diagnostic, therapeutic, or application guidance.